Abstract
Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate.
X M Yang, Z P Luo and J H Zhou
Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 358-363;